Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2005;5(3):173–181. doi: 10.1007/s11882-005-0034-8

Nasal cytokines as mediators of illness during the common cold

William J Doyle 1, David P Skoner 1, Deborah Gentile 1
PMCID: PMC7089508  PMID: 15842953

Abstract

Identification of a pharmacologically targeted mediator of the common cold is a desirable, but, to date, elusive goal of current research. The roles of various mediators, such as histamine, leukotrienes, bradykinin, and, more recently, chemokines and cytokines, in the pathophysiology and development of complications of the common cold are the subject of previous and current investigations. Establishing causality of a mediator in the common cold has been difficult for a number of reasons, including the limitations of our research tools and protocols and the complexity of the inflammatory and immune pathways that participate during the common cold. The available evidence for mediation of the common cold is the subject of this manuscript.

Keywords: Influenza, Respiratory Syncytial Virus, Allergy Clin Immunol, Respiratory Syncytial Virus Infection, Common Cold

References and Recommended Reading

  • 1.Eggleston PA, Hendley JO, Gwaltney JM., Jr. Mediators of immediate hypersensitivity in nasal secretions during natural colds and rhinovirus infection. Acta Otolaryngol Suppl. 1984;413:25–35. doi: 10.3109/00016488409128538. [DOI] [PubMed] [Google Scholar]
  • 2.Naclerio RM, Proud D, Kagey-Sobotka A, et al. Is histamine responsible for the symptoms of rhinovirus colds? A look at the inflammatory mediators following infection. Pediatr Infect Dis J. 1988;7:218–222. doi: 10.1097/00006454-198803000-00031. [DOI] [PubMed] [Google Scholar]
  • 3.Naclerio RM, Proud D, Lichtenstein LM, et al. Kinins are generated during experimental rhinovirus colds. J Infect Dis. 1988;157:133–142. doi: 10.1093/infdis/157.1.133. [DOI] [PubMed] [Google Scholar]
  • 4.Demoly P, Crampette L, Mondain M, et al. Assessment of inflammation in noninfectious chronic maxillary sinusitis. J Allergy Clin Immunol. 1994;94:95–108. doi: 10.1016/0091-6749(94)90076-0. [DOI] [PubMed] [Google Scholar]
  • 5.McCormick DP, Saeed K, Uchida T, et al. Middle ear fluid histamine and leukotriene B4 in acute otitis media: effect of antihistamine or corticosteroid treatment. Int J Pediatr Otorhinolaryngol. 2003;67:221–230. doi: 10.1016/S0165-5876(02)00372-5. [DOI] [PubMed] [Google Scholar]
  • 6.Birch L, Elbrond O. Presence of interferon in the middle ear during secretory otitis media. Acta Otolaryngol. 1987;104:468–471. doi: 10.3109/00016488709128276. [DOI] [PubMed] [Google Scholar]
  • 7.Yellon RF, Doyle WJ, Whiteside TL. Cytokines, immunoglobulins, and bacterial pathogens in middle ear effusions. Arch Otolaryngol Head Neck Surg. 1995;121:865–869. doi: 10.1001/archotol.1995.01890080033006. [DOI] [PubMed] [Google Scholar]
  • 8.Repka-Ramirez S, Naranch K, Park YJ, et al. Cytokines in nasal lavage fluids from acute sinusitis, allergic rhinitis, and chronic fatigue syndrome subjects. Allergy Asthma Proc. 2002;23:185–190. [PubMed] [Google Scholar]
  • 9.Hayden FG, Fritz R, Lobo MC, et al. Local and systemic cytokine responses during experimental human influenza A virus infection: relation to symptom formation and host defense. J Clin Invest. 1998;101:643–649. doi: 10.1172/JCI1355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.McCormick DP, John SD, Swischuk LE, Uchida T. A doubleblind, placebo-controlled trial of decongestant-antihistamine for the treatment of sinusitis in children. Clin Pediatr (Phila) 1996;35:457–460. doi: 10.1177/000992289603500905. [DOI] [PubMed] [Google Scholar]
  • 11.Gwaltney JM, Jr, Winther B, Patrie JT, Hendley JO. Combined antiviral-antimediator treatment for the common cold. J Infect Dis. 2002;186:147–154. doi: 10.1086/341455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Hayden FG. Update on influenza and rhinovirus infections. Adv Exp Med Biol. 1999;458:55–67. doi: 10.1007/978-1-4615-4743-3_6. [DOI] [PubMed] [Google Scholar]
  • 13.Heikkinen T, Jarvinen A. The common cold. Lancet. 2003;361:51–59. doi: 10.1016/S0140-6736(03)12162-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Bertino JS. Cost burden of viral respiratory infections: issues for formulary decision makers. Am J Med. 2002;112(Suppl 6A):42S–49S. doi: 10.1016/S0002-9343(01)01063-4. [DOI] [PubMed] [Google Scholar]
  • 15.Bramley TJ, Lerner D, Sames M. Productivity losses related to the common cold. J Occup Environ Med. 2002;44:822–829. doi: 10.1097/00043764-200209000-00004. [DOI] [PubMed] [Google Scholar]
  • 16.Brouwer WB, van Exel NJ, Koopmanschap MA, Rutten FF. Productivity costs before and after absence from work: as important as common. Health Policy. 2002;61:173–187. doi: 10.1016/S0168-8510(01)00233-0. [DOI] [PubMed] [Google Scholar]
  • 17.Doyle WJ, McBride TP, Skoner DP, et al. A double-blind, placebo-controlled clinical trial of the effect of chlorpheniramine on the response of the nasal airway, middle ear and eustachian tube to provocative rhinovirus challenge. Pediatr Infect Dis J. 1988;7:229–238. doi: 10.1097/00006454-198803000-00033. [DOI] [PubMed] [Google Scholar]
  • 18.Doyle WJ, Skoner DP, Alper CM, et al. Effect of rimantadine treatment on clinical manifestations and otologic complications in adults experimentally infected with influenza A (H1N1) virus. J Infect Dis. 1998;177:1260–1265. doi: 10.1086/515294. [DOI] [PubMed] [Google Scholar]
  • 19.Doyle WJ, Alper CM, Buchanan CA, et al. Illness and otological changes during upper respiratory virus infection. Laryngoscope. 1999;109(2 Pt 1):324–328. doi: 10.1097/00005537-199902000-00027. [DOI] [PubMed] [Google Scholar]
  • 20.Hagglund H. Allergies or colds. J Okla Dent Assoc. 1984;75:30, 31, 34–30, 31, 34. [PubMed] [Google Scholar]
  • 21.Tyrrell DA, Cohen S, Schlarb JE. Signs and symptoms in common colds. Epidemiol Infect. 1993;111:143–156. doi: 10.1017/S0950268800056764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Schaffer J: The metaphysics of causation. In The Stanford Encyclopedia of Philosophy. Edited by Zalta EN. http://plato.stanford. edu/archives/spr2003/entries/causation-metaphysics/ (Spring 2003)
  • 23.Doyle WJ, Boehm S, Skoner DP. Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy. J Allergy Clin Immunol. 1990;86(6 Pt 1):924–935. doi: 10.1016/S0091-6749(05)80156-3. [DOI] [PubMed] [Google Scholar]
  • 24.Skoner DP, Doyle WJ, Boehm S, Fireman P. Effect of terfenadine on nasal, eustachian tube, and pulmonary function after provocative intranasal histamine challenge. Ann Allergy. 1991;67:619–624. [PubMed] [Google Scholar]
  • 25.Bose S, Banerjee AK. Innate immune response against nonsegmented negative strand RNA viruses. J Interferon Cytokine Res. 2003;23:401–412. doi: 10.1089/107999003322277810. [DOI] [PubMed] [Google Scholar]
  • 26.Bender BS, Small PA., Jr Influenza: pathogenesis and host defense. Semin Respir Infect. 1992;7:38–45. [PubMed] [Google Scholar]
  • 27.Igarashi Y, Skoner DP, Doyle WJ, et al. Analysis of nasal secretions during experimental rhinovirus upper respiratory infections. J Allergy Clin Immunol. 1993;92:722–731. doi: 10.1016/0091-6749(93)90016-9. [DOI] [PubMed] [Google Scholar]
  • 28.Doyle WJ, Skoner DP, White M, et al. Pattern of nasal secretions during experimental influenza virus infection. Rhinology. 1996;34:2–8. [PubMed] [Google Scholar]
  • 29.Proud D, Naclerio RM, Gwaltney JM, Hendley JO. Kinins are generated in nasal secretions during natural rhinovirus colds. J Infect Dis. 1990;161:120–123. doi: 10.1093/infdis/161.1.120. [DOI] [PubMed] [Google Scholar]
  • 30.Proud D, Reynolds CJ, Lacapra S, et al. Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis. 1988;137:613–616. doi: 10.1164/ajrccm/137.3.613. [DOI] [PubMed] [Google Scholar]
  • 31.Skoner DP, Gentile DA, Fireman P, et al. Urinary histamine metabolite elevations during experimental influenza infection. Ann Allergy Asthma Immunol. 2001;87:303–306. doi: 10.1016/s1081-1206(10)62244-2. [DOI] [PubMed] [Google Scholar]
  • 32.Gentile DA, Fireman P, Skoner DP. Elevations of local leukotriene C4 levels during viral upper respiratory tract infections. Ann Allergy Asthma Immunol. 2003;91:270–274. doi: 10.1016/S1081-1206(10)63529-6. [DOI] [PubMed] [Google Scholar]
  • 33.Higgins PG, Barrow GI, Tyrrell DA. A study of the efficacy of the bradykinin antagonist, NPC 567, in rhinovirus infections in human volunteers. Antiviral Res. 1990;14:339–344. doi: 10.1016/0166-3542(90)90052-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Gustafson LM, Proud D, Hendley JO, et al. Oral prednisone therapy in experimental rhinovirus infections. J Allergy Clin Immunol. 1996;97:1009–1014. doi: 10.1016/S0091-6749(96)80077-7. [DOI] [PubMed] [Google Scholar]
  • 35.Sperber SJ, Sorrentino JV, Riker DK, Hayden FG. Evaluation of an alpha agonist alone and in combination with a nonsteroidal antiinflammatory agent in the treatment of experimental rhinovirus colds. Bull N Y Acad Med. 1989;65:145–160. [PMC free article] [PubMed] [Google Scholar]
  • 36.Sperber SJ, Hendley JO, Hayden FG, et al. Effects of naproxen on experimental rhinovirus colds: a randomized, doubleblind, controlled trial. Ann Intern Med. 1992;117:37–41. doi: 10.7326/0003-4819-117-1-37. [DOI] [PubMed] [Google Scholar]
  • 37.Gwaltney JM., Jr Combined antiviral and antimediator treatment of rhinovirus colds. J Infect Dis. 1992;166:776–782. doi: 10.1093/infdis/166.4.776. [DOI] [PubMed] [Google Scholar]
  • 38.Turner RB, Sperber SJ, Sorrentino JV, et al. Effectiveness of clemastine fumarate for treatment of rhinorrhea and sneezing associated with the common cold. Clin Infect Dis. 1997;25:824–830. doi: 10.1086/515546. [DOI] [PubMed] [Google Scholar]
  • 39.Muether PS, Gwaltney JM., Jr Variant effect of first- and second-generation antihistamines as clues to their mechanism of action on the sneeze reflex in the common cold. Clin Infect Dis. 2001;33:1483–1488. doi: 10.1086/322518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Gwaltney JM, Jr, Buier RM, Rogers JL. The influence of signal variation, bias, noise and effect size on statistical significance in treatment studies of the common cold. Antiviral Res. 1996;29:287–295. doi: 10.1016/0166-3542(95)00935-3. [DOI] [PubMed] [Google Scholar]
  • 41.Borish L, Rosenwasser LJ. Update on cytokines. J Allergy Clin Immunol. 1996;97:719–733. doi: 10.1016/S0091-6749(96)80146-1. [DOI] [PubMed] [Google Scholar]
  • 42.Yoon HJ, Zhu Z, Gwaltney JM, Jr, Elias A. Rhinovirus regulation of IL-1 receptor antagonist in vivo and in vitro: a potential mechanism of symptom resolution. J Immunol. 1999;162:7461–7469. [PubMed] [Google Scholar]
  • 43.Zhu Z, Tang W, Ray A, et al. Rhinovirus stimulation of interleukin- 6 in vivo and in vitro: evidence for nuclear factor kappa B-dependent transcriptional activation. J Clin Invest. 1996;97:421–430. doi: 10.1172/JCI118431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Zhu Z, Tang W, Gwaltney JM, Jr, et al. Rhinovirus stimulation of interleukin-8 in vivo and in vitro: role of NF-kappaB. Am J Physiol. 1997;273(4 Pt 1):L814–L824. doi: 10.1152/ajplung.1997.273.4.L814. [DOI] [PubMed] [Google Scholar]
  • 45.Gentile DA, Yokitis J, Angelini BL, et al. Effect of intranasal challenge with interleukin-6 on upper airway symptomatology and physiology in allergic and nonallergic patients. Ann Allergy Asthma Immunol. 2001;86:531–536. doi: 10.1016/S1081-1206(10)62901-8. [DOI] [PubMed] [Google Scholar]
  • 46.Gentile DA, Doyle WJ, Belenky S, et al. Nasal and oral nitric oxide levels during experimental respiratory syncytial virus infection of adults. Acta Otolaryngol. 2002;122:61–66. doi: 10.1080/00016480252775751. [DOI] [PubMed] [Google Scholar]
  • 47.Gern JE, Martin MS, Anklam KA, et al. Relationships among specific viral pathogens, virus-induced interleukin-8, and respiratory symptoms in infancy. Pediatr Allergy Immunol. 2002;13:386–393. doi: 10.1034/j.1399-3038.2002.01093.x. [DOI] [PubMed] [Google Scholar]
  • 48.Noah TL, Henderson FW, Henry MM, et al. Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis. 1995;171:584–592. doi: 10.1093/infdis/171.3.584. [DOI] [PubMed] [Google Scholar]
  • 49.Roseler S, Holtappels G, Wagenmann M, Bachert C. Elevated levels of interleukins IL-1 beta, IL-6 and IL-8 in naturally acquired viral rhinitis. Eur Arch Otorhinolaryngol. 1995;252(Suppl 1):S61–S63. doi: 10.1007/BF02484437. [DOI] [PubMed] [Google Scholar]
  • 50.Kaiser L, Fritz RS, Straus SE, et al. Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J Med Virol. 2001;64:262–268. doi: 10.1002/jmv.1045. [DOI] [PubMed] [Google Scholar]
  • 51.Proud D, Gwaltney JM, Jr, Hendley JO, et al. Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds. J Infect Dis. 1994;169:1007–1013. doi: 10.1093/infdis/169.5.1007. [DOI] [PubMed] [Google Scholar]
  • 52.Turner RB, Weingand KW, Yeh CH, Leedy DW. Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds. Clin Infect Dis. 1998;26:840–846. doi: 10.1086/513922. [DOI] [PubMed] [Google Scholar]
  • 53.Yuta A, Doyle WJ, Gaumond E, et al. Rhinovirus infection induces mucus hypersecretion. Am J Physiol. 1998;274(6):L1017–L1023. doi: 10.1152/ajplung.1998.274.6.L1017. [DOI] [PubMed] [Google Scholar]
  • 54.Gern JE, Vrtis R, Grindle KA, et al. Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Respir Crit Care Med. 2000;162:2226–2231. doi: 10.1164/ajrccm.162.6.2003019. [DOI] [PubMed] [Google Scholar]
  • 55.Gentile DA, Villalobos E, Angelini B, Skoner D. Cytokine levels during symptomatic viral upper respiratory tract infection. Ann Allergy Asthma Immunol. 2003;91:362–367. doi: 10.1016/S1081-1206(10)61683-3. [DOI] [PubMed] [Google Scholar]
  • 56.Linden M, Greiff L, Andersson M, et al. Nasal cytokines in common cold and allergic rhinitis. Clin Exp Allergy. 1995;25:166–172. doi: 10.1111/j.1365-2222.1995.tb01022.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Noah TL, Becker S. Chemokines in nasal secretions of normal adults experimentally infected with respiratory syncytial virus. Clin Immunol. 2000;97:43–49. doi: 10.1006/clim.2000.4914. [DOI] [PubMed] [Google Scholar]
  • 58.Gentile D, Doyle W, Whiteside T, et al. Increased interleukin-6 levels in nasal lavage samples following experimental influenza A virus infection. Clin Diagn Lab Immunol. 1998;5:604–608. doi: 10.1128/cdli.5.5.604-608.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Cohen S, Doyle WJ, Skoner DP. Psychological stress, cytokine production, and severity of upper respiratory illness. Psychosom Med. 1999;61:175–180. doi: 10.1097/00006842-199903000-00009. [DOI] [PubMed] [Google Scholar]
  • 60.Skoner DP, Gentile DA, Patel A, Doyle WJ. Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus. J Infect Dis. 1999;180:10–14. doi: 10.1086/314823. [DOI] [PubMed] [Google Scholar]
  • 61.Fritz RS, Hayden FG, Calfee DP, et al. Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. J Infect Dis. 1999;180:586–593. doi: 10.1086/314938. [DOI] [PubMed] [Google Scholar]
  • 62.Bonville CA, Rosenberg HF, Domachowske JB. Macrophage inflammatory protein-1alpha and RANTES are present in nasal secretions during ongoing upper respiratory tract infection. Pediatr Allergy Immunol. 1999;10:39–44. doi: 10.1034/j.1399-3038.1999.101005.x. [DOI] [PubMed] [Google Scholar]
  • 63.Sheeran P, Jafri H, Carubelli C, et al. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis J. 1999;18:115–122. doi: 10.1097/00006454-199902000-00007. [DOI] [PubMed] [Google Scholar]
  • 64.Hornsleth A, Klug B, Nir M, et al. Severity of respiratory syncytial virus disease related to type and genotype of virus and to cytokine values in nasopharyngeal secretions. Pediatr Infect Dis J. 1998;17:1114–1121. doi: 10.1097/00006454-199812000-00003. [DOI] [PubMed] [Google Scholar]
  • 65.Hornsleth A, Loland L, Larsen LB. Cytokines and chemokines in respiratory secretion and severity of disease in infants with respiratory syncytial virus (RSV) infection. J Clin Virol. 2001;21:163–170. doi: 10.1016/S1386-6532(01)00159-7. [DOI] [PubMed] [Google Scholar]
  • 66.Oh JW, Lee HB, Park IK, Kany JO. Interleukin-6, interleukin-8, interleukin-11, and interferon-gamma levels in nasopharyngeal aspirates from wheezing children with respiratory syncytial virus or influenza A virus infection. Pediatr Allergy Immunol. 2002;13:350–356. doi: 10.1034/j.1399-3038.2002.02018.x. [DOI] [PubMed] [Google Scholar]
  • 67.Garofalo RP, Hintz KH, Hill V, et al. Production of interferon gamma in respiratory syncytial virus infection of humans is not associated with interleukins 12 and 18. J Med Virol. 2004;73:289–294. doi: 10.1002/jmv.20089. [DOI] [PubMed] [Google Scholar]
  • 68.Gentile DA, Doyle WJ, Zeevi A, et al. Cytokine gene polymorphisms moderate illness severity in infants with respiratory syncytial virus infection. Hum Immunol. 2003;64:338–344. doi: 10.1016/S0198-8859(02)00827-3. [DOI] [PubMed] [Google Scholar]
  • 69.Gentile DA, Doyle WJ, Zeevi A, et al. Cytokine gene polymorphisms moderate responses to respiratory syncytial virus in adults. Hum Immunol. 2003;64:93–98. doi: 10.1016/S0198-8859(02)00705-X. [DOI] [PubMed] [Google Scholar]
  • 70.Skoner DP, Doyle WJ, Seroky J, Fireman P, et al. Lower airway responses to influenza A virus in healthy allergic and nonallergic subjects. Am J Respir Crit Care Med. 1996;154(3 Pt 1):661–664. doi: 10.1164/ajrccm.154.3.8810602. [DOI] [PubMed] [Google Scholar]
  • 71.Gentile DA, Doyle WJ, Fireman P, Skoner DP. Effect of experimental influenza A infection on systemic immune and inflammatory parameters in allergic and nonallergic adult subjects. Ann Allergy Asthma Immunol. 2001;87:496–500. doi: 10.1016/S1081-1206(10)62263-6. [DOI] [PubMed] [Google Scholar]

Articles from Current Allergy and Asthma Reports are provided here courtesy of Nature Publishing Group

RESOURCES